MA27006A1 - Compositions virocides. - Google Patents

Compositions virocides.

Info

Publication number
MA27006A1
MA27006A1 MA27326A MA27326A MA27006A1 MA 27006 A1 MA27006 A1 MA 27006A1 MA 27326 A MA27326 A MA 27326A MA 27326 A MA27326 A MA 27326A MA 27006 A1 MA27006 A1 MA 27006A1
Authority
MA
Morocco
Prior art keywords
virocidal
compositions
viruses
composition
effective
Prior art date
Application number
MA27326A
Other languages
English (en)
Inventor
Thomas W Konowalchuk
Jack Konowalchuk
Original Assignee
Thomas W Konowalchuk
Jack Konowalchuk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/795,279 external-priority patent/US7399790B2/en
Application filed by Thomas W Konowalchuk, Jack Konowalchuk filed Critical Thomas W Konowalchuk
Publication of MA27006A1 publication Critical patent/MA27006A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

COMPOSITIONS VIROCIDES Procédé d'inactivation de virus comprenant la mise en contact du virus avec une quantité efficace au niveau virocide d'une composition constituée essentiellement d'un alcool monohydroxy en Cl à C3 ou d'un diol en C2 à C4 et d'une quantité suffisante d'un acide afin d'ajuster le pH de la composition en dessous de 4,6. L'administration topique de la composition est préférée et est efficace pour traiter des lésions associées aux infections par des virus telles que l'herpès simplex. Les formes pouvant être délivrées par voie nasale sont efficaces pour traiter les symptômes causés par les virus à l'origine du rhume. Des compositions pharmaceutiques à utiliser dans le présent procédé sont proposées.
MA27326A 2001-02-28 2003-09-26 Compositions virocides. MA27006A1 (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US09/795,279 US7399790B2 (en) 2001-02-28 2001-02-28 Virucidal compositions
US10/016,282 US7902258B2 (en) 2001-02-28 2001-12-06 Methods for preventing lesions caused by viruses of the Herpesviridae or Poxviridae family
US10/016,189 US7045548B2 (en) 2001-02-28 2001-12-06 Methods of inactivating viruses
US10/021,533 US7268163B2 (en) 2001-02-28 2001-12-06 Method for treating an inflammation or lesion caused by a virus

Publications (1)

Publication Number Publication Date
MA27006A1 true MA27006A1 (fr) 2004-12-20

Family

ID=27486551

Family Applications (1)

Application Number Title Priority Date Filing Date
MA27326A MA27006A1 (fr) 2001-02-28 2003-09-26 Compositions virocides.

Country Status (15)

Country Link
EP (1) EP1372389B1 (fr)
JP (1) JP2004529889A (fr)
CN (1) CN1264513C (fr)
AU (1) AU2002251933B2 (fr)
BR (1) BR0207703A (fr)
CA (1) CA2439413C (fr)
EA (1) EA005917B1 (fr)
IL (1) IL157596A0 (fr)
IS (1) IS2860B (fr)
MA (1) MA27006A1 (fr)
MX (1) MXPA03007748A (fr)
NO (1) NO333867B1 (fr)
NZ (1) NZ527931A (fr)
PL (1) PL365700A1 (fr)
WO (1) WO2002069887A2 (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7399790B2 (en) 2001-02-28 2008-07-15 Konowalchuk Thomas W Virucidal compositions
ES2527504T3 (es) * 2006-02-09 2015-01-26 Gojo Industries, Inc. Método antivírico
EP2040544A2 (fr) * 2006-05-26 2009-04-01 The Dial Corporation Procédé d'inhibition de la transmission de virus
US8034844B2 (en) 2006-05-30 2011-10-11 The Dial Corporation Compositions having a high antiviral efficacy
US8337872B2 (en) * 2006-06-02 2012-12-25 The Dial Corporation Method of inhibiting the transmission of influenza virus
BRPI0622061B8 (pt) * 2006-10-23 2021-05-25 Ecolab Inc composição viricida, uso e produto compreendendo a mesma
WO2010047108A1 (fr) * 2008-10-24 2010-04-29 メルシャン株式会社 Procédé d'inactivation de calicivirus
WO2010082587A1 (fr) * 2009-01-13 2010-07-22 株式会社大気倶楽部 Adsorbant pour suspension dans l'air
WO2011072728A1 (fr) 2009-12-16 2011-06-23 Ecolab Inc. Composition sous forme de gel utilisée pour la désinfection virucide de la peau d'un mammifère
US20160166624A1 (en) * 2012-10-19 2016-06-16 Flutrends International, Llc Anti-viral compositions
FR3033576B1 (fr) * 2015-03-13 2018-11-16 Fondation Mediterranee Infection Methode d'inactivation d'un agent infectieux dans un echantillon biologique
CN108300705B (zh) * 2017-01-12 2021-10-22 厦门大学 稳定呼吸道合胞病毒融合蛋白的方法
KR20190102898A (ko) * 2018-02-27 2019-09-04 지에스칼텍스 주식회사 2,3-부탄디올을 유효성분으로 포함하는 조성물

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4975217A (en) * 1981-07-20 1990-12-04 Kimberly-Clark Corporation Virucidal composition, the method of use and the product therefor
US4647458A (en) * 1981-09-25 1987-03-03 Kabushiki Kaisha Ueno Seiyaku Oyo Kenkyujo Liquid bactericide for foods and food processing machines or utensils, employing a synergistic mixture of ethyl alcohol, an organic acid and phosphoric acid
CA1221640A (fr) * 1984-03-07 1987-05-12 Nicola Pamukoff Composes pharmaceutiques pour le traitement des infections virales
GB8604986D0 (en) * 1986-02-28 1986-04-09 Unilever Plc Disinfectant compositions
DE3622089A1 (de) * 1986-07-02 1988-01-07 Krueger Gmbh & Co Kg Viruzides mittel mit breitbandwirkung
US5405602A (en) * 1989-01-31 1995-04-11 Simmons; Paul L. Nonaqueous cold sterilant
US6034133A (en) * 1993-11-05 2000-03-07 The University Of Virginia Patents Foundation Use of a virucidal hand lotion to prevent the spread of rhinovirus colds
US6350724B1 (en) * 1999-04-20 2002-02-26 Effcon Laboratories, Inc. Lice removing composition

Also Published As

Publication number Publication date
IL157596A0 (en) 2004-03-28
EP1372389A4 (fr) 2004-03-31
CA2439413C (fr) 2017-01-03
EA005917B1 (ru) 2005-06-30
IS2860B (is) 2013-12-15
NO20033829D0 (no) 2003-08-28
NZ527931A (en) 2006-02-24
WO2002069887A2 (fr) 2002-09-12
NO333867B1 (no) 2013-10-07
WO2002069887A3 (fr) 2003-01-09
AU2002251933B2 (en) 2008-01-17
EP1372389A2 (fr) 2004-01-02
CA2439413A1 (fr) 2002-09-12
PL365700A1 (en) 2005-01-10
JP2004529889A (ja) 2004-09-30
CN1264513C (zh) 2006-07-19
EP1372389B1 (fr) 2011-10-05
CN1505478A (zh) 2004-06-16
IS6933A (is) 2003-08-27
BR0207703A (pt) 2004-10-05
MXPA03007748A (es) 2004-03-16
NO20033829L (no) 2003-10-27
EA200300843A1 (ru) 2004-06-24

Similar Documents

Publication Publication Date Title
MA27006A1 (fr) Compositions virocides.
JP3434435B2 (ja) ふけ形成抑制効果を有する毛髪化粧料組成物
ATE526956T1 (de) Viruzide zusammensetzungen
BE1006233A3 (fr) Composition pour application nasale.
IL120317A0 (en) Otic antibacterial compositions
RU93053493A (ru) Сульфатная соль (2:1)-3-[2-(диметиламино)этил]-n-метил-1н-индол-5-метансульфонамида и ее фармацевтически приемлемые сольваты, способ их получения, фармацевтические композиции на их основе, их применение в терапии, способ лечения головной боли
CA2330500A1 (fr) Compositions pharmaceutiques gelifiables
RU2009149687A (ru) Фармацевтические композиции и способы лечения сухих кератитов
HRP20130071T1 (hr) Poboljšani testosteron u gelu i naäśin primjene
KR970701049A (ko) 포스페티딜콜린과 착물화된 프로스타글란딘 e1 및/또는 트록세루틴을 함유하는 발기불능 국부 치료용 조성물(compositions containing prostaglandin e1 and or troxerutine complexed with phosphatidylcholine for topical treatment of erectile impotence)
AU2012215383B2 (en) Novel antifungal composition
JP2006501225A5 (fr)
EP1198223A2 (fr) Composition ophthalmique contenant de la ketotifene
NO20002798L (no) Sammensetninger og metoder for Õ øke konsentrasjonen og/eller bevegeligheten av spermatozoa hos mennesker
IS7311A (is) Lyfjafræðileg samsetning sem samanstendur af sýklósporíni og notkun á henni
JPH0912452A (ja) ジクロフェナクナトリウム含有乳化外用剤
MA29508B1 (fr) Compositions détergentes sous forme de microémulsions et leur utilisation dans le traitement de l'alopécie
ES2295161T3 (es) Solucion oftalmica.
MA27662A1 (fr) Procede pour la fabrication d'une composition pharmaceutique sous la forme de comprimes contenant un fibrate et comprimes obtenus selon le procede
JP4849288B2 (ja) 点眼剤及び涙液膜の安定化剤
KR950031084A (ko) 국소용 진양(鎭洋) 조성물
JP2002510653A5 (fr)
FI974444A (fi) N-hydroksiureayhdisteitä anti-inflammatorisina aineina
FR2954701A1 (fr) Compositions dermatologiques contenant une association de lipides peroxydes et de zinc et leurs utilisations notamment dans le traitement de l'herpes
RU2004101940A (ru) Средство для лечения воспалительных и дегенеративных заболеваний суставов, имплантант синовиальной жидкости, способ лечения воспалительных и дегенеративных заболеваний суставов (варианты) и устройство для доставки лекарственного средства к поражённому участку